Former FDA Administrator Crawford pleads guilty to conflicts of interest

NewsGuard 100/100 Score

Lester Crawford, who resigned as FDA commissioner in September 2005, on Tuesday pleaded guilty in U.S. District Court to charges of false reporting and conflicts of interest related to ownership of stocks in companies that are regulated by the agency, the AP/Philadelphia Inquirer reports (Bridges, AP/Philadelphia Inquirer, 10/18).

On Monday, the Department of Justice charged Crawford with the two misdemeanors, each of which carries a maximum penalty of one year in prison.

Barbara Van Gelder, Crawford's attorney, said she expects him to be fined and placed on probation.

DOJ said Crawford and his wife owned stock in FDA-regulated companies -- including Wal-Mart; poultry biotechnology company Embrex; food and beverage maker PepsiCo; food distributor Sysco; and Kimberly-Clark, which makes some consumer health care products -- while he held senior positions at FDA but failed to disclose the holdings and made false statements about the couple's ownership of some of the stocks (Kaiser Daily Health Policy Report, 10/17).

Magistrate Judge Deborah Robinson accepted Crawford's guilty plea and scheduled a sentencing hearing for Jan. 22, 2007 (Stout, New York Times, 10/18).

After the arraignment, Crawford said, "This was my fault and no one else's," adding, "Nothing that I have done, I hope, can be construed to affect the integrity of the FDA" (AP/Philadelphia Inquirer, 10/18).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research sheds light on how GLP-1 obesity drugs may change food cravings